Subscribe: WSJ.com: Health
http://online.wsj.com/xml/rss/3_7089.xml
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
act  affordable care  affordable  billion  buy  care act  care  deal  drug  health  marathon pharmaceuticals  pharmaceuticals  price  trump 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: WSJ.com: Health

WSJ.com: Health



Health



Last Build Date: Sun, 26 Feb 2017 23:10:02 EST

Copyright: copyright © 2017 Dow Jones & Company, Inc.
 



GOP Leaders Dare Fellow Republicans to Block Obamacare Repeal

Sun, 26 Feb 2017 22:51:49 EST

Republican leaders are betting that the only way for Congress to repeal the Affordable Care Act is to set a bill in motion and gamble that fellow GOP lawmakers won’t dare to block it.



Facing Criticism, Drug Makers Keep Lid On Price Increases

Sun, 26 Feb 2017 20:22:19 EST

Pharmaceutical companies held most of their traditional January list-price increases to under 10% this year, although the median boost was little-changed from 2016. Among the critics they face now is President Trump.



How to Get Patients to Take More Control of Their Medical Decisions

Sun, 26 Feb 2017 23:08:40 EST

For years, people have been urged be more active in their own care. Now providers are giving them better tools to make that happen.



GOP Governors at Health-Law Impasse

Sun, 26 Feb 2017 21:15:51 EST

Governors meeting Saturday to discuss health-care policy said they hadn’t reached a consensus on the future of the Medicaid program, an issue hamstringing Republicans’ bid to alter the Affordable Care Act.



Carl Icahn Takes Stake in Bristol-Myers

Wed, 22 Feb 2017 12:47:40 EST

The same day Bristol-Myers Squibb shook up its board to satisfy one activist investor, the drugmaker was faced with another: Carl Icahn, whose interest is fueling speculation the company could soon be put on the auction block.



Tyson Seeks Lead in No-Antibiotics Poultry

Tue, 21 Feb 2017 13:13:08 EST

Tyson Foods Inc. plans to eliminate antibiotics used on poultry in its flagship chicken products, as the largest U.S. meat company mounts a new push to burnish its brands.



Trump Administration Seeks Delay in Lawsuit Over Health-Law Subsidies

Wed, 22 Feb 2017 10:24:17 EST

The Trump administration and House Republicans on Tuesday asked a court for a further delay in a lawsuit over certain Affordable Care Act subsidies, a move that may help assuage insurers debating whether to participate in the health law’s 2018 exchanges.



Trump Backing for Bayer's Monsanto Deal Buoys Investors

Mon, 20 Feb 2017 22:52:52 EST

Investors in Bayer have taken heart from President Donald Trump’s apparent support for the German pharmaceuticals and chemicals firm’s planned $57 billion takeover of U.S. seed giant Monsanto.



Antitrust Rulings Put Chill on Health-Insurance Mergers

Wed, 15 Feb 2017 09:47:10 EST

Cigna called off the roughly $48 billion merger with Anthem and filed a lawsuit against its suitor, the second such health-insurer deal to fall apart.



Merck Stops Clinical Trial of Alzheimer's Drug

Tue, 14 Feb 2017 18:37:01 EST

Merck & Co. said Tuesday it stopped a clinical trial of an experimental Alzheimer’s drug because it wasn’t helping patients.



Door Opens to Gene Editing in Embryos

Tue, 14 Feb 2017 22:08:05 EST

The nonprofit National Academies of Sciences and the National Academy of Medicine commissioned a study of the ethical, scientific and regulatory questions raised by editing genes in sperm, eggs and early-stage embryos.



The Rise and Fall of a K Street Renegade

Mon, 13 Feb 2017 18:05:35 EST

Evan Morris, a high-flying corporate lobbyist, is suspected by federal prosecutors of embezzling millions of dollars from his employers, Roche and then Genentech. The probe is shaping up to be one of the biggest Washington influence scandals in years.



Teva Swings to Loss, But Beats Expectations

Mon, 13 Feb 2017 23:05:01 EST

Teva Pharmaceuticals swung to a loss on an acquisition write-down, as its interim CEO contends with a deal-driven debt load, though shares rose as the company beat revenue and profit expectations.



Firm Delays Muscular Dystrophy Drug Launch Amid Criticism of $89,000 Price

Tue, 14 Feb 2017 10:01:14 EST

Marathon Pharmaceuticals will delay the U.S. launch of its muscular dystrophy drug amid mounting criticism of its $89,000-a-year price, including from two members of Congress who launched an investigation Monday.



Allergan to Buy Fat-Treatment Maker Zeltiq for $2.3 Billion

Mon, 13 Feb 2017 17:46:54 EST

Allergan PLC said it would buy Zeltiq Aesthetics Inc., the maker of a fat-reducing treatment, for $2.26 billion.



No Drugs for Back Pain, New Guidelines Say

Tue, 14 Feb 2017 00:37:45 EST

The American College of Physicians says back pain of all kinds should be treated with natural and alternative therapies, such as exercise, acupuncture and mindfulness.



Hospitals Weigh Difficult Choice Amid Travel-Ban Uncertainty

Sun, 12 Feb 2017 20:24:18 EST

Hospital officials say President Donald Trump’s executive order leaves them with a difficult choice: forgo strong residency candidates from countries named in the order or risk vacancies if foreign doctors are barred from the U.S.



70-Fold Price Increase Puts Drug at $89,000

Sat, 11 Feb 2017 00:09:51 EST

Marathon Pharmaceuticals will charge $89,000 annually in the U.S. for a decades-old steroidal drug that was approved for U.S. sale for the first time on Thursday, a price that is as much as 70 times higher than the drug’s price overseas.



Reckitt Benckiser to Buy Mead Johnson for $16.6 Billion

Fri, 10 Feb 2017 17:14:42 EST

Reckitt Benckiser said it agreed to buy baby-food maker Mead Johnson for $16.6 billion, a cash deal that will almost double the size of the British company’s consumer-health business and help it push deeper into emerging markets.



As HHS Head, Price Has Wide Latitude to Shape Obamacare's Fate

Fri, 10 Feb 2017 16:47:52 EST

The Georgia Republican was approved in a party-line vote Friday morning, placing him atop a sprawling agency tasked with dismantling the Affordable Care Act.